Cargando…
Proteomic meta-study harmonization, mechanotyping and drug repurposing candidate prediction with ProHarMeD
Proteomics technologies, which include a diverse range of approaches such as mass spectrometry-based, array-based, and others, are key technologies for the identification of biomarkers and disease mechanisms, referred to as mechanotyping. Despite over 15,000 published studies in 2022 alone, leveragi...
Autores principales: | Adamowicz, Klaudia, Arend, Lis, Maier, Andreas, Schmidt, Johannes R., Kuster, Bernhard, Tsoy, Olga, Zolotareva, Olga, Baumbach, Jan, Laske, Tanja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564802/ https://www.ncbi.nlm.nih.gov/pubmed/37816770 http://dx.doi.org/10.1038/s41540-023-00311-7 |
Ejemplares similares
-
Screening cell mechanotype by parallel microfiltration
por: Qi, Dongping, et al.
Publicado: (2015) -
Single Cell Mechanotype and Associated Molecular Changes in Urothelial Cell Transformation and Progression
por: Yu, Weibo, et al.
Publicado: (2020) -
RAD-TGTs: high-throughput measurement of cellular mechanotype via rupture and delivery of DNA tension probes
por: Pawlak, Matthew R., et al.
Publicado: (2023) -
Drugst.One - A plug-and-play solution for online systems medicine and network-based drug repurposing
por: Maier, Andreas, et al.
Publicado: (2023) -
DIGGER: exploring the functional role of alternative splicing in protein interactions
por: Louadi, Zakaria, et al.
Publicado: (2020)